BE902911A - Derives n-imidazolyliques et leur preparation - Google Patents

Derives n-imidazolyliques et leur preparation

Info

Publication number
BE902911A
BE902911A BE0/215362A BE215362A BE902911A BE 902911 A BE902911 A BE 902911A BE 0/215362 A BE0/215362 A BE 0/215362A BE 215362 A BE215362 A BE 215362A BE 902911 A BE902911 A BE 902911A
Authority
BE
Belgium
Prior art keywords
radical
preparation
compounds
symbols
hydrogen atom
Prior art date
Application number
BE0/215362A
Other languages
English (en)
Inventor
P Cozzi
G Carganico
U Branzoli
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of BE902911A publication Critical patent/BE902911A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Des composés de la formule (I) dans laquelle chacun des symboles R1, R2, R3 et R4 qui peuvent avoir des significations identiques ou différentes, représente un atome d'hydrogène; un atome d'halogène; un radical hydroxyle; un radical cyano, un radical alkyle en C1-C6; un radical alcoxy en C1-C6; un radical acyle en C2-C4 ou un radical acylamino en C2-C4; un radical -SR', -NR'R'', -CH2OR', -CONR'R'', -CH2NR'R'', -PO(OR')2, -CH2COOR', -CH2CONR'R où chacun des symboles R' et R'', qui peuvent avoir des significations identiques ou différentes, représente un atome d'hydrogène ou un radical alkyle en C1-C6, ainsi que les sels pharmaceutiquement acceptables de ces composés. Utilisation pour le traitement des migraines.
BE0/215362A 1984-07-17 1985-07-16 Derives n-imidazolyliques et leur preparation BE902911A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08418220A GB2161801B (en) 1984-07-17 1984-07-17 N-imidazolyl derivatives and process for their preparation

Publications (1)

Publication Number Publication Date
BE902911A true BE902911A (fr) 1986-01-16

Family

ID=10564020

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/215362A BE902911A (fr) 1984-07-17 1985-07-16 Derives n-imidazolyliques et leur preparation

Country Status (4)

Country Link
JP (1) JPS6140282A (fr)
BE (1) BE902911A (fr)
DE (1) DE3519432A1 (fr)
GB (1) GB2161801B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984627B1 (en) 1993-06-03 2006-01-10 Astrazeneca Ab Peptide derivatives
SE0001803D0 (sv) 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i

Also Published As

Publication number Publication date
DE3519432A1 (de) 1986-01-23
JPS6140282A (ja) 1986-02-26
GB8418220D0 (en) 1984-08-22
GB2161801A (en) 1986-01-22
GB2161801B (en) 1987-10-07

Similar Documents

Publication Publication Date Title
BE902213A (fr) Composes de phenethanolamine.
CA1260471C (fr)
IL60390A (en) Piperidine derivatives,their preparation and pharmaceutical compositions comprising them
IL66009A (en) 2-aryl-3,4-diazabicyclo(4.n.o)alk-2-en-5-ones,their preparation and pharmaceutical compositions containing them
BE901436A (fr) Antibiotiques du type cephalosporine, leur procede de preparation, intermediaires pour leur preparation et compositions therapeutiques les contenant
ATE41772T1 (de) Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
AU611113B2 (en) Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds
FR2455587A1 (fr) Derives de benzimidazole, leur preparation et utilisation dans le traitement des affections cardiovasculaires et compositions les contenant
BE902911A (fr) Derives n-imidazolyliques et leur preparation
BE904983A (fr) Acides propenylaminothiazolylcephalosporaniques 3-substitues et leurs esters.
BE904864A (fr) Derives de la quinoleine, leur procede de preparation et compositions pharmaceutiques les contenant.
DE3468875D1 (en) Substituted isoquinoline derivatives, method for their preparation, and pharmaceutical compositions containing these compounds
FR2603284A1 (fr) Derives d'acide 7-oxabicyclo(2.2.1.)heptane hydroxamique a action therapeutique
BE1003280A3 (fr) Derives oxo-isoindoliniques optiquement actifs.
BE899118A (fr) Derives du n-pyridylpyrazole et composition herbicide les contenant.
FR2412562A1 (fr) Nouveaux derives de 6'-epi-fortimicines a et b utiles notamment comme agents antibacteriens, procede et intermediaires pour leur preparation et composition pharmaceutique les contenant
BE1000719A4 (fr) Derives de 3-(hydroxymethyl)-isoquinoleine, procede pour les preparer et compositions pharmaceutiques les contenant.
FR2452495A1 (fr) 2-epi-fortimicines a et b et leurs derives, utiles notamment comme antibiotiques, et intermediaires pour leur preparation
DE3169918D1 (en) Cis-c3",c4"-carbonate derivatives of oleandomycin-y, pharmaceutical compositions containing them, and intermediates therefor
BE904016A (fr) Nouveaux derives naphtaleniques du benzonorbornene, leur procede de preparation et compositions medicamenteuse et cosmetique les contenant
IL67324A0 (en) New dehydrocardenolide derivatives,process for the preparation thereof and pharmaceutical preparations containing the same
FR2456110A2 (fr) Nouveaux derives de l'isoquinoleine, leur preparation et les compositions qui les contiennent
NZ216741A (en) 6-oxo-1,6-dihydropyridazines and pharmaceutical compositions
BE902014A (fr) Nouvelles 13,14,19,20-tetradehydro-carboprostacyclines et procede de preparation.
EP0292365A3 (fr) Dérivés de l'amino-4 quinazolinedione-5,8, leur procédé de préparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: FARMITALIA CARLO ERBA S.P.A.

Effective date: 19900731